Literature DB >> 18314345

Light-guided surgery to repair coronary sinus orifice atresia with left superior vena cava.

Yukihiro Kaneko1, Jotaro Kobayashi, Yusuke Yamamoto, Keiji Tsuchiya.   

Abstract

An 8-month-old male with coronary sinus orifice atresia, left superior vena cava, and single ventricle underwent light-guided coronary sinus unroofing concomitant with bidirectional cavopulmonary anastomosis to circumvent coronary sinus hypertension. During surgery, a 2.25 Fr angioscopic catheter was inserted into the coronary sinus via the left superior vena cava. The coronary sinus, lit by the illumination obtained from the catheter, was readily located from the left atrial interior, and unroofed. Light-guided coronary sinus unroofing is an easy, safe, and quick technique for the creation of unobstructed coronary sinus drainage in patients with coronary sinus orifice atresia and left superior vena cava.

Entities:  

Mesh:

Year:  2008        PMID: 18314345     DOI: 10.1016/j.ejcts.2008.01.048

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Coronary sinus ostial atresia associated with functionally single ventricle: persistent left superior vena cava should be ligated upon coronary sinus unroofing and bidirectional Glenn shunt.

Authors:  Hyung-Tae Sim; Jung-Jin Yu; Hyun-Woo Goo; Tae-Jin Yun
Journal:  Pediatr Cardiol       Date:  2012-05-17       Impact factor: 1.655

2.  Early detection of anomalous origin of left coronary artery from the right pulmonary artery after successful repair of critical coarctation of the aorta.

Authors:  Levent Celik; Vera Becker; Dieter Hammel; Jan-Hendrik Nürnberg
Journal:  Pediatr Cardiol       Date:  2009-12-04       Impact factor: 1.655

3.  Clinical Features and Surgical Outcomes of Coronary Sinus Orifice Atresia.

Authors:  Naoki Tadokoro; Takaya Hoashi; Koji Kagisaki; Masatoshi Shimada; Kenichi Kurosaki; Isao Shiraishi; Hajime Ichikawa
Journal:  Pediatr Cardiol       Date:  2015-10-26       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.